Document is current
Any future updates will be listed below
-
Authors
Berenbaum, Francis https://orcid.org/0000-0001-8252-7815
- License Information
-
More Information
Article History
Received: 27 February 2025
Revised: 10 June 2025
Accepted: 11 June 2025
First Online: 20 June 2025
Declarations
:
: Not applicable.
: Dr. Francis Berenbaum is the CEO of 4Moving Biotech. 4Moving Biotech and Sorbonne University own two patents for the method of use of GLP1 analogs in the treatment of osteoarthritis (PCT/FR2013/051998 and PCT/IB2018//059100).
